cytarabine and Astrocytoma, Grade IV

cytarabine has been researched along with Astrocytoma, Grade IV in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19904 (20.00)18.7374
1990's2 (10.00)18.2507
2000's9 (45.00)29.6817
2010's4 (20.00)24.3611
2020's1 (5.00)2.80

Authors

AuthorsStudies
Mathen, P; Smart, DK1
Gangoso, E; Marques-Torrejon, MA; Pollard, SM1
Chen, HD; He, JX; Miao, ZH; Tian, YN; Wang, YT; Xu, L; Yuan, B; Zhang, A1
Gurion, R; Hamlin, P; Horwitz, S; Lunning, M; Mehta, N; Migliacci, JC; Moskowitz, A; Moskowitz, C; Zelenetz, A1
Chung, SP; El Sayed, SM; El-Magd, RM; Fukui, K; Kagami, S; Sakai, T; Shishido, Y; Tran, DH; Watanabe, H; Yorita, K1
Chamberlain, MC1
Weller, M1
Camitta, BM; Casper, JT; Eapen, M; Keever-Taylor, CA; Margolis, DA; Murray, KJ; Pierce, KL; Talano, JM1
Gojkovic, Z; Hasholt, L; Joergensen, T; Knecht, W; Le Breton, C; Munch-Petersen, B; Piskur, J; Rozpedowska, E; Sandrini, MP; Willer, M1
Anderluh, G; Borges, HL; de Faria, GP; Gabilan, NH; Moura-Neto, V; Soletti, RC; Terenzi, H; Vernal, J1
Aitkens, S; Belanger, G; Benoit, B; Dennery, J; Grahovac, Z; Hugenholtz, H; Peterson, E; Richard, MT; Russell, N; Stewart, DJ1
Adle-Biassette, H; Authier, FJ; Chomienne, C; Defer, GL; Degos, JD; Degos, L; Martin, L; Ricolfi, F1
Hori, S; Kawashima, H; Mori, T; Morikawa, N; Takeyama, M1
Bours, V; Gielen, J; Malgrange, B; Martin, D; Merville, M; Moonen, G; Princen, F; Robe, PA; Stevenaert, A1
Abe, T; Hori, S; Kawashima, H; Mori, T; Morikawa, N; Takeyama, M1
Anders, K; Fahlbusch, R; Fietkau, R; Grabenbauer, GG; Krauseneck, P; Sauer, R; Schuchardt, U1
Deininger, MH; Grote, E; Meyermann, R; Wickboldt, J1
Bleyer, WA; Geyer, JR; Heideman, RL; Kosnik, EJ; Milstein, JM; Morris, JD; Mulne, AF; Pendergrass, TW; Ruymann, FB; Stuntz, JT1
Hahn, E; Maruyama, Y; Schwartz, S; Thomson, JM1
Chen, TT; Mealey, J1

Reviews

1 review(s) available for cytarabine and Astrocytoma, Grade IV

ArticleYear
[Standards and new developments in the chemotherapy of glioblastomas].
    Deutsche medizinische Wochenschrift (1946), 2005, Oct-07, Volume: 130, Issue:40

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Cytarabine; Dacarbazine; Decanoic Acids; DNA Modification Methylases; Glioblastoma; Humans; Nimustine; Polyesters; Promoter Regions, Genetic; Temozolomide; Teniposide

2005

Trials

2 trial(s) available for cytarabine and Astrocytoma, Grade IV

ArticleYear
All-trans retinoic acid in relapsing malignant gliomas: clinical and radiological stabilization associated with the appearance of intratumoral calcifications.
    Journal of neuro-oncology, 1997, Volume: 34, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Calcinosis; Cytarabine; Disease Progression; Female; Glioblastoma; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Radiography; Time Factors; Tretinoin

1997
Accelerated radiotherapy with concomitant ACNU/Ara-C for the treatment of malignant glioma.
    Journal of neuro-oncology, 2000, Volume: 48, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Brain Neoplasms; Combined Modality Therapy; Cytarabine; Female; Glioblastoma; Humans; Male; Middle Aged; Nimustine; Radiotherapy; Survival Rate

2000

Other Studies

17 other study(ies) available for cytarabine and Astrocytoma, Grade IV

ArticleYear
Reimagining external beam radiotherapy for glioblastoma: "old beam, new trick".
    Neuro-oncology, 2021, 03-25, Volume: 23, Issue:3

    Topics: Carmustine; Cytarabine; Etoposide; Glioblastoma; Humans

2021
Modelling glioblastoma tumour-host cell interactions using adult brain organotypic slice co-culture.
    Disease models & mechanisms, 2018, 02-22, Volume: 11, Issue:2

    Topics: Aging; Animals; Antigens, CD; Biomarkers, Tumor; Brain; Brain Neoplasms; Cell Communication; Cell Proliferation; Coculture Techniques; Culture Media, Serum-Free; Cytarabine; Dacarbazine; Disease Models, Animal; Endothelial Cells; Glioblastoma; Humans; Mice, Inbred C57BL; Neoplastic Stem Cells; Neural Stem Cells; Organ Specificity; Stem Cell Niche; Temozolomide; Tumor Microenvironment; Xenograft Model Antitumor Assays

2018
Acquired resistance of phosphatase and tensin homolog-deficient cells to poly(ADP-ribose) polymerase inhibitor and Ara-C mediated by 53BP1 loss and SAMHD1 overexpression.
    Cancer science, 2018, Volume: 109, Issue:3

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cytarabine; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; PTEN Phosphohydrolase; SAM Domain and HD Domain-Containing Protein 1; Tumor Suppressor p53-Binding Protein 1

2018
Central nervous system involvement in T-cell lymphoma: A single center experience.
    Acta oncologica (Stockholm, Sweden), 2016, Volume: 55, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Female; Glioblastoma; Humans; Incidence; Injections, Spinal; Lactate Dehydrogenases; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell, Peripheral; Male; Methotrexate; Middle Aged; Neoplasm Staging; Practice Guidelines as Topic; Prognosis; Recurrence; Retrospective Studies; Risk Factors; Young Adult

2016
D-Amino acid oxidase-induced oxidative stress, 3-bromopyruvate and citrate inhibit angiogenesis, exhibiting potent anticancer effects.
    Journal of bioenergetics and biomembranes, 2012, Volume: 44, Issue:5

    Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Cell Line, Tumor; Chelating Agents; Cisplatin; Citric Acid; Cytarabine; D-Amino-Acid Oxidase; Drug Resistance, Neoplasm; Energy Metabolism; Enzyme Inhibitors; Glioblastoma; Hexokinase; Human Umbilical Vein Endothelial Cells; Humans; Hydrogen Peroxide; Mice; Neovascularization, Pathologic; Oxidative Stress; Pyruvates

2012
Combined-modality treatment of leptomeningeal gliomatosis.
    Neurosurgery, 2003, Volume: 52, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Cohort Studies; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Disease Progression; Female; Follow-Up Studies; Glioblastoma; Humans; Male; Meningeal Neoplasms; Methotrexate; Middle Aged; Radiotherapy, Adjuvant; Survival Rate; Treatment Outcome; Triethylenephosphoramide

2003
Alternative donor bone marrow transplant for children with Philadelphia chromosome ALL.
    Bone marrow transplantation, 2006, Volume: 37, Issue:2

    Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Disease-Free Survival; Donor Selection; Female; Glioblastoma; Graft vs Host Disease; Humans; Immunosuppressive Agents; Lymphocyte Depletion; Male; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Recurrence; Retrospective Studies; Transplantation Conditioning; Whole-Body Irradiation

2006
Drosophila deoxyribonucleoside kinase mutants with enhanced ability to phosphorylate purine analogs.
    Gene therapy, 2007, Volume: 14, Issue:17

    Topics: Animals; Antimetabolites; Antineoplastic Agents; Cell Line, Tumor; Cladribine; Cytarabine; Directed Molecular Evolution; Drosophila melanogaster; Genes, Transgenic, Suicide; Genetic Therapy; Glioblastoma; Humans; Lethal Dose 50; Mutation; Neoplasms; Osteosarcoma; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Purines; Substrate Specificity; Transduction, Genetic; Vidarabine

2007
Potentiation of anticancer-drug cytotoxicity by sea anemone pore-forming proteins in human glioblastoma cells.
    Anti-cancer drugs, 2008, Volume: 19, Issue:5

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cnidarian Venoms; Cytarabine; Doxorubicin; Drug Synergism; Glioblastoma; Humans; Pore Forming Cytotoxic Proteins; Sea Anemones; Vincristine

2008
Cisplatin plus cytosine arabinoside in adults with malignant gliomas.
    Journal of neuro-oncology, 1984, Volume: 2, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Bone Marrow Diseases; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Cytarabine; Female; Gastrointestinal Diseases; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local

1984
Pharmacokinetics of anticancer drugs in cerebrospinal fluid.
    The Annals of pharmacotherapy, 1998, Volume: 32, Issue:10

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Administration Routes; Female; Glioblastoma; Humans; Injections, Spinal; Methotrexate; Nimustine; Perfusion

1998
Pharmacological modulation of the bystander effect in the herpes simplex virus thymidine kinase/ganciclovir gene therapy system: effects of dibutyryl adenosine 3',5'-cyclic monophosphate, alpha-glycyrrhetinic acid, and cytosine arabinoside.
    Biochemical pharmacology, 2000, Jul-15, Volume: 60, Issue:2

    Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Bucladesine; Connexin 43; Connexins; Cytarabine; Drug Screening Assays, Antitumor; Ganciclovir; Gap Junctions; Genetic Therapy; Glioblastoma; Glycyrrhetinic Acid; Phosphorylation; Rats; RNA, Messenger; Simplexvirus; Thymidine Kinase; Transfection; Tumor Cells, Cultured

2000
Pharmacokinetics of cytosine arabinoside, methotrexate, nimustine and valproic acid in cerebrospinal fluid during cerebrospinal fluid perfusion chemotherapy.
    Biological & pharmaceutical bulletin, 2000, Volume: 23, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Female; Glioblastoma; Humans; Methotrexate; Nimustine; Valproic Acid

2000
Distinct radiochemotherapy protocols differentially influence cellular proliferation and expression of p53 and Bcl-2 in glioblastoma multiforme relapses in vivo.
    Journal of neuro-oncology, 2000, Volume: 48, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers; Brain Neoplasms; Cell Division; Chemotherapy, Adjuvant; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Genes; Genes, bcl-2; Glioblastoma; GTP-Binding Proteins; Humans; Ki-67 Antigen; Life Tables; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Nimustine; Protein Glutamine gamma Glutamyltransferase 2; Proto-Oncogene Proteins c-bcl-2; Radiotherapy, Adjuvant; Survival Analysis; Teniposide; Transglutaminases; Tumor Suppressor Protein p53

2000
Eight drugs in one day chemotherapy for brain tumors: experience in 107 children and rationale for preradiation chemotherapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1987, Volume: 5, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Drug Evaluation; Glioblastoma; Humans; Hydroxyurea; Lomustine; Medulloblastoma; Methylprednisolone; Neoplasm Recurrence, Local; Procarbazine; Vincristine

1987
Effect of chemotherapy and-or head irradiation on survival of mice with intracranial glioma.
    Radiology, 1971, Volume: 101, Issue:1

    Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Copper; Cytarabine; Disease Models, Animal; Ependymoma; Female; Glioblastoma; Hematoporphyrins; Male; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Nitroso Compounds; Nitrosourea Compounds; Porphyrins; Radiotherapy; Urea

1971
Effects of cytosine arabinoside and 1,3-bis(2-chloroethyl)-1-nitrosourea on human glial tumor cells.
    Cancer research, 1972, Volume: 32, Issue:3

    Topics: Brain Neoplasms; Cell Count; Cell Line; Cells, Cultured; Cytarabine; Depression, Chemical; Drug Combinations; Glioblastoma; Humans; In Vitro Techniques; Nitroso Compounds; Nitrosourea Compounds; Urea

1972